- Report
- June 2025
- 123 Pages
India
From €5376EUR$5,995USD£4,610GBP
- Report
- June 2025
- 134 Pages
South Korea
From €5376EUR$5,995USD£4,610GBP
- Report
- June 2025
- 123 Pages
Italy
From €5376EUR$5,995USD£4,610GBP
- Report
- June 2025
- 126 Pages
Germany
From €5376EUR$5,995USD£4,610GBP
- Report
- June 2025
- 126 Pages
France
From €5376EUR$5,995USD£4,610GBP
- Report
- June 2025
- 122 Pages
United Kingdom
From €5376EUR$5,995USD£4,610GBP
- Report
- June 2025
- 182 Pages
United States
From €5376EUR$5,995USD£4,610GBP
- Report
- June 2025
- 140 Pages
Japan
From €1372EUR$1,530USD£1,177GBP
€1614EUR$1,800USD£1,384GBP
- Report
- May 2025
- 191 Pages
Global
From €4439EUR$4,950USD£3,806GBP
- Report
- May 2025
- 102 Pages
Global
From €2645EUR$2,950USD£2,268GBP
- Report
- May 2025
- 76 Pages
Africa, Middle East
From €2645EUR$2,950USD£2,268GBP
- Report
- May 2025
- 80 Pages
From €2645EUR$2,950USD£2,268GBP
- Report
- May 2025
- 95 Pages
Asia Pacific
From €3094EUR$3,450USD£2,653GBP
- Report
- May 2025
- 98 Pages
Europe
From €3094EUR$3,450USD£2,653GBP
- Report
- May 2025
- 88 Pages
North America
From €2645EUR$2,950USD£2,268GBP
- Report
- April 2025
- 210 Pages
Global
From €4035EUR$4,500USD£3,460GBP
- Report
- April 2025
- 180 Pages
Global
From €4349EUR$4,850USD£3,729GBP
- Report
- March 2025
- 131 Pages
Global
From €4349EUR$4,850USD£3,729GBP
- Report
- February 2025
- 130 Pages
Global
From €4349EUR$4,850USD£3,729GBP
- Report
- October 2024
- 141 Pages
Poland
From €1372EUR$1,530USD£1,177GBP
€1614EUR$1,800USD£1,384GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more